Sökresultat

To strengthen the engagement of the Swedish scientific community in ESS, Sweden has now officially become part of the ESS in-kind community with four projects selected by ESS and the Swedish Research Council. To strengthen the engagement of the Swedish scientific community in the European Spallation Source (ESS), Sweden has now officially become part of the ESS in-kind community with a number of c

https://www.lp3.lu.se/article/sweden-enters-kind-agreement-ess-lp3-contributes-deuteration-lab-services - 2026-07-07

The Deuteration Network (DeuNet) is an international network which aims to facilitate access to deuteration services. The Deuteration Network (DeuNet) (external webpage) is an international network of deuteration facilities and laboratories which aims to facilitate access to deuteration services and customised deuterium labelling of molecules and biomolecules for use in neutron research and in oth

https://www.lp3.lu.se/article/new-deunet-webpage-now-launched - 2026-07-07

All staff from LP3, which is one out of five nodes in the PPS national infrastructure, participated. The distributed national research infrastructure Protein Production Sweden (PPS, see external website) did meet for its second annual staff retreat at Ljunglöfska slottet in Stockholm. The 25 staff researchers of PPS attending used the two day meeting (28/29th September 2023) to discuss and reflect

https://www.lp3.lu.se/article/annual-pps-retreat-stockholm - 2026-07-07

Recently, a book chapter with protocols for the Baculovirus Expression Vector System in insect cells was published by LP3. Lund Protein Production Platform (LP3) has recently published its standard operating procedures for recombinant protein expression using the Baculovirus Expression Vector System (BEVS) in insect cells. Read the full book chapter here at Springer Link (external website)LP3 prov

https://www.lp3.lu.se/article/new-publication-about-bevs-lp3 - 2026-07-07

Members of the board and scientific committee of PPS, Sabine Suppmann and Kim Remans, respectively are among the authors of a new review in Star Protocols about expression systems for recombinant protein production. The overview is based on a survey with 60 leading experts in protein production about their experiences and practices in using different expression systems for recombinant protein prod

https://www.lp3.lu.se/article/guide-choosing-expression-system-recombinant-proteins - 2026-07-07

Lund Protein Production Platform (LP3) is featured in EUGLOHRIA Talks and EUGLOHRIA Virtual Tours approaching audiences with interactive and innovative content and an interview with the head of LP3, Dr. Wolfgang Knecht, is now available on the EUGLOHRIA homepage. The European University Alliance for Global Health – Transformation through Joint Research and Innovation Action (EUGLOHRIA, external li

https://www.lp3.lu.se/article/lund-protein-production-platform-featured-euglohria-talks-and-euglohria-virtual-tours - 2026-07-07

At the first 2024 management meeting, SciLifeLab Lund welcomed LP3 as a new local core facility. The aim of the local SciLifeLab sites in Umeå, Linköping, Gothenburg and Lund is to bring national infrastructure activities closer to the research communities at these locations, and to contribute to increased synergies and collaborations with multiple stakeholders.SciLifeLab Lund (external webpage) w

https://www.lp3.lu.se/article/lp3-newest-local-core-facility-scilifelab-lund - 2026-07-07

LP3 with Celeste Sele presented its capabilities in Protein Characterisation, Crystallisation and Structure Determination at the 35th MAX IV user meeting in Lund (external homepage). LP3 is harboring a local node of Protein Production Sweden (PPS). PPS focuses on the production and purification of (mainly) recombinant protein reagents for all Swedish researchers. The Director of PPS, Malin Bäckstr

https://www.lp3.lu.se/article/lp3-and-pps-35th-max-iv-user-meeting - 2026-07-07

LP3 is now part of "Pandemics and Alertness", a collaboration initiative for virus-related topics by Lund University Pandermics and Alertness is an interdisciplinary platform created to promote collaboration and change of information between stakeholders, researchers and experts from different disciplines, and public authorities to improve our knowledge of the impact of pandemics on the society. A

https://www.lp3.lu.se/article/pandemics-and-alertness - 2026-07-07

Together with DEMAX (see external wesite), the Lund Protein Production Platform (LP3) recently published a new protocol for the use of algal autolysate for the production of deuterium-labeled recombinant protein featuring:Continuous cultivation and autolysis of deuterated B. brauniiAutolysate used as glycerol substitute in recombinant protein productionUsing autolysate gives high protein yield and

https://www.lp3.lu.se/article/demax-and-lp3-publish-new-protocol-use-algal-autolysate-production-deuterium-labeled-recombinant - 2026-07-07

InfraLife Project Coordinator, Claire Lyons, came for a site visit at LP3 InfraLife is a national initiative to improve knowledge and availability of infrastructures and make it accessible to Life science researchers in academia, industry and health care. Read more about the visit here at InfraLife news (external webpage).  More information about InfraLife can be found on the InfraLife homepage (e

https://www.lp3.lu.se/article/visit-infralife-lp3 - 2026-07-07

The WCMM Lund IGNITE Postdoc Fellow Program was officially launched with a welcoming dinner on Wednesday, 21 January, marking the start of a new postdoctoral initiative in regenerative medicine. The event gathered WCMM Fellows, clinical researchers, supervisors, IGNITE Fellows and members of WCMM Lund management for an evening focused on connection and collaboration. Set in a relaxed and inspiring

https://www.wcmm.lu.se/article/welcoming-dinner-marks-official-launch-wcmm-lund-ignite-postdoc-fellow-program - 2026-07-07

Johannes Cairns has joined Lund University’s Wallenberg Centre for Molecular Medicine (WCMM) as the latest DDLS Fellow. Cairns brings cutting-edge expertise in laboratory-guided evolution, genetic engineering, and bioinformatics to tackle one of medicine’s most pressing challenges: antibiotic resistance. His work will combine experimental microbiology with quantitative genomics to better understan

https://www.wcmm.lu.se/article/welcome-wcmm-johannes-cairns-joins-new-ddls-fellow - 2026-07-07

The WCMM & DDLS Leadership Seminar Series, an initiative designed to equip WCMM & DDLS Lund PIs with leadership skills essential for shaping the future of medical science, has now held its second session of 2026. On 11 February, we were delighted to welcome KArin Jirström, Vice Dean responsible for PhD studies and campus development, as our invited speaker. Karin gave an in-depth overview of the F

https://www.wcmm.lu.se/article/wcmm-ddls-leadership-seminar-fun-research-education-board - 2026-07-07

Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely guide bone repair without triggering strong immune responses. The transplant has been successfully tested in animal models, and the next step is to evaluate the tissue engineering approach in humans.

https://www.wcmm.lu.se/article/universal-method-could-transform-future-bone-transplantation - 2026-07-07

Bringing together clinical insight and molecular research is essential for advancing modern medicine. With the appointment of Lisa Rydén as new Clinical Co-Director at the Wallenberg Centre for Molecular Medicine Lund, the centre aims to further strengthen the bridge between healthcare and academic research environments in Lund. A professor of surgery with long-standing experience in translational

https://www.wcmm.lu.se/article/lisa-ryden-appointed-clinical-co-director-wcmm-lund-strengthen-translational-research - 2026-07-07

WCMM Fellow Iben Lundgaard has received major international funding from the Lundbeck Foundation to advance research into the brain’s glymphatic system, strengthening Nordic collaboration and accelerating efforts to translate emerging neuroscience discoveries into clinical practice. WCMM Fellow Iben Lundgaard has been awarded a prestigious research grant from the Lundbeck Foundation, providing jus

https://www.wcmm.lu.se/article/major-research-grant-awarded-wcmm-fellow-iben-lundgaard - 2026-07-07

The Faculty of Medicine at Lund University has launched the new Centre for Research Infrastructure in Health and Life Sciences (CRI), bringing together key research infrastructures under a shared organizational framework. As of 1 January 2026, Wallenberg Center for Molecular Medicine (WCMM) Lund is part of the new centre, marking an important step toward stronger coordination and collaboration in

https://www.wcmm.lu.se/article/wcmm-lund-part-new-centre-research-infrastructure-health-and-life-sciences - 2026-07-07

Understanding the brain requires a seamless connection between fundamental science and patient care. With Gesine Paul-Visse’s appointment, we strengthen translational neuroscience, uniting laboratory discoveries, clinical expertise and education to tackle complex neurological and psychiatric disorders. Understanding diseases of the brain requires insight that spans from cellular mechanisms to pati

https://www.wcmm.lu.se/article/gesine-paul-visse-appointed-vigre-professorship-neuropsychiatric-research - 2026-07-07

Knut and Alice Wallenberg Foundation is allocating additional funds to patient‑oriented, clinical research. The initiative will, among other things, strengthen research at the four Wallenberg Centres for Molecular Medicine located in Gothenburg, Lund, Linköping, and Umeå, as well as at Karolinska Institutet and Uppsala University. We are thrilled to announce that the Knut and Alice Wallenberg Foun

https://www.wcmm.lu.se/article/knut-and-alice-wallenberg-foundation-allocates-sek-16-billion-life-science-focus-clinical-research - 2026-07-07